TJX
55
2
URI
49
3
CTAS
43
3
CMI
75
4
RSG
45
-2
SLG
37
6
LMT
62
3
M
53
-5
XOM
50
5
NOV
55
3
ICE
60
3
STI
21
3
DOW
42
2
PAYX
41
5
TAP
37
8
KSS
58
-4
GOOG
59
2
CME
52
7
CVX
28
3
MU
79
4
TJX
55
2
URI
49
3
CTAS
43
3
CMI
75
4
RSG
45
-2
SLG
37
6
LMT
62
3
M
53
-5
XOM
50
5
NOV
55
3
ICE
60
3
STI
21
3
DOW
42
2
PAYX
41
5
TAP
37
8
KSS
58
-4
GOOG
59
2
CME
52
7
CVX
28
3
MU
79
4
Financhill
Back

SPDR S&P Global Natural Resources ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
43

GNR
SPDR S&P Global Natural Resources ETF

Last Price:
$62.17
Seasonality Move:
1.98%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Sell
43
SPDR S&P Global Natural Resources ETF (GNR) is a Sell

Is SPDR S&P Global Natural Resources ETF a Buy, Sell or Hold?

  • The current SPDR S&P Global Natural Resources ETF [GNR] share price is $62.04. The Score for GNR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • GNR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GNR Stock Price Chart

What is SPDR S&P Global Natural Resources ETF's stock price today?

  • The SPDR S&P Global Natural Resources ETF share price today is $62.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GNR is experiencing slight buying pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

GNR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.54 Buy
Relative Strength Index (14 RSI): 57.57 Buy
Chaikin Money Flow: 113694 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.66 - 62.04) Buy
Bollinger Bands (100): (56.9 - 60.66) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

GNR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.79 Buy
20-day SMA: 61.3 Buy
50-day SMA: 60 Buy
200-day SMA: 56.03 Buy
8-day EMA: 61.59 Buy
20-day EMA: 61.2 Buy
50-day EMA: 59.3 Buy
200-day EMA: 37.86 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

SPDR S&P Global Natural Resources ETF Earnings Growth & GNR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

SPDR S&P Global Natural Resources ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):